Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study)
Non-conventional
em En
| ARCA
| ID: arc-40857
Texto completo:
1
Coleções:
06-national
Base de dados:
ARCA
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Non-conventional